$1.010
+0.052 (+5.15%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GANX por análisis de gráficos similares
Alphio's GANX stock price prediction model matches the current Gain Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.02 (+0.70%). The 1-week path is $1.01 (+0.37%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Gain Therapeutics Inc?
Currently, Gain Therapeutics Inc (GANX) is trading at $1.13, significantly below its 52-week high of $4.34, indicating a potential undervaluation. However, the RSI is at a low 25.78, suggesting the stock is oversold, which could indicate a buying opportunity. The company has reported a narrower loss of $4.67 million in Q2 2026, down from $5.81 million a year ago, showing improved financial performance. The main risk is the ongoing negative earnings trend, with a projected EPS of -0.13 for the next earnings report on November 11, 2026.
GANX cerró en $1.01 el Friday, tras subir +5.15%
Gain Therapeutics Inc (GANX) last closed at $1.0099, gaining +5.15%. These facts feed the 1-day and 1-week GANX price prediction above.
Factores de la previsión
Los factores de la previsión de Gain Therapeutics Inc (GANX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GANX, ordenadas por similitud.
Análisis de estacionalidad de GANX
Historically the probability of a positive November return for GANX is 31.82%. February offers the highest probability of a positive month at 53.45%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.